NCT00547014 - First Safety Study in Humans of a Single Dose of CPG 52364 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Study Completion Date

April 30, 2008

Conditions

Healthy Volunteers

Interventions

DRUG

Placebo Comparator: Cohort 1 Placebo

Drug: placebo for cohort 1 as single dose

DRUG

52364 3 mg

3 mg capsule single dose administered orally as a single dose

DRUG

Placebo Comparator: Cohorts 2, 3, 4 & 5 Two subjects each arm will be assigned to receive placebo

Drug: Placebo for cohorts 2, 3, 4 and 5 administered as a single dose

DRUG

52364 10 mg

Drug: 52364 30 mg capsule as a single dose

DRUG

52364 30 mg

Drug: 52364 30 mg capsule administered as a single dose

DRUG

52364 100 mg

Drug 52364 100 mg capsule administered as a single dose

DRUG

52364 1 mg

1 mg powder diluted in liquid or placebo (liquid alone) administered orally as a single dose

Trial Locations (1)

Pfizer Investigational Site, Overland Park